11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Coverage (8)
- Weight-loss drugs surge in popularity, but many Americans still aren't using them WBFF · 47d ago
- Weight-loss drugs surge in popularity, but many Americans still aren't using them KOMO · 47d ago
- Weight-loss drugs surge in popularity, but many Americans still aren't using them KATU · 47d ago
- Americans are taking GLP-1 drugs in record numbers The Washington Post · 47d ago
- U.S. Obesity Rate Drops As GLP-1 Usage Grows Forbes · 47d ago
- In U.S., GLP-1 Usage Reaches New High Gallup News · 47d ago
- More Americans Than Ever Are Taking Weight-Loss Drugs The New York Times · 47d ago
- 11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy Gizmodo · 47d ago broke it first
Where it stands
"11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy" is generating significant coverage in the Business category, with 8 articles from 8 distinct sources tracked by Newsylist so far.
Outlets currently covering the story include WBFF, KOMO, KATU and The Washington Post. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by Newsylist's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by Newsylist's extractive engine from coverage metadata only — no AI-written claims. Updated 44d ago.
Answered
Why is "11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy" trending?
Because 8 independent news sources published 8 articles about it in a short window — a coverage burst Newsylist classifies as a trend.
How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
Researchers find new benefits, risks in GLP-1 weight loss drugs
Scientists uncover unexpected benefits and new risks surrounding widely used GLP-1 weight loss medications.
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
GLP-1 weight loss drugs: What experts say about keeping weight off after stopping
Use of GLP-1 weight loss medications has reached a new high in the United States, sparking debate over long-term efficacy and accessibility.
Are You Getting Enough Vitamin D? Here’s Everything You Need to Know About Taking the Supplement
Health experts and researchers are re-evaluating the role of sunlight and supplementation in maintaining healthy Vitamin D levels this summer.
One in eight U.S. adults uses GLP-1 drugs; Medicare now opens weight-loss access
Medicare now provides access to GLP-1 weight-loss drugs as utilization rates among U.S. adults reach one in eight.
Compounded GLP-1 drugs creating concern among doctors and FDA
Compounded GLP-1 weight‑loss drugs face mounting scrutiny as doctors and regulators flag safety concerns.